Clinical Trial Update: Statin Contrast Induced Nephropathy Prevention [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating statin therapy for the prevention of contrast-induced nephropathy in patients with acute coronary syndrome. The study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Statin therapy (statin)

Snippet

Sponsor: Centro Cardiopatici Toscani | Conditions: Acute Coronary Syndrome | Phase 4 | Status: COMPLETED